Cargando…
Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time?
SIMPLE SUMMARY: Pancreatic cancer is a deadly cancer with limited treatment options. It is often detected in most people at stages where cure is not possible. There is no good test to know if a person will respond to treatment or if there is any disease beyond what can be seen by available imaging t...
Autores principales: | Sheel, Ankur, Addison, Sarah, Nuguru, Surya Pratik, Manne, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322623/ https://www.ncbi.nlm.nih.gov/pubmed/35884515 http://dx.doi.org/10.3390/cancers14143453 |
Ejemplares similares
-
Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
por: Jeepalyam, Sravan, et al.
Publicado: (2023) -
Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Jiang, Joanna, et al.
Publicado: (2022) -
Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2021) -
Is sperm DNA fragmentation testing ready for prime time?
por: Jarvi, Keith A.
Publicado: (2017) -
Sperm DNA fragmentation testing: ready for prime time?
por: Oehninger, Sergio
Publicado: (2017)